Literature DB >> 25663014

Combined extrahepatic bile duct resection for locally advanced gallbladder carcinoma: does it work?

Tsuyoshi Igami1, Tomoki Ebata, Yukihiro Yokoyama, Gen Sugawara, Takashi Mizuno, Junpei Yamaguchi, Yoshie Shimoyama, Masato Nagino.   

Abstract

BACKGROUND: Prophylactic combined extrahepatic bile duct resection remains controversial for locally advanced gallbladder carcinoma without extrahepatic bile duct invasion. The aim of this study is to resolve this issue and establish an appropriate surgery for locally advanced gallbladder carcinoma.
METHODS: A total of 52 patients underwent surgical resection combined with extrahepatic bile duct resection for locally advanced gallbladder carcinoma without extrahepatic bile duct invasion, and their medical records were retrospectively reviewed for microvessel invasion (MVI), including lymphatic, venous, and/or perineural invasions, around the extrahepatic bile duct.
RESULTS: Of the 52 patients, 8 (15 %) had MVI around the extrahepatic bile duct. All of the 8 patients had Stage IV disease. According to a survival analysis of the 50 patients who tolerated surgery, MVIs around the extrahepatic bile duct and distant metastasis were identified as independent prognostic factors. Survival for patients with MVI around the extrahepatic bile duct was dismal, with a lack of 2-year survivors.
CONCLUSIONS: MVI around the extrahepatic bile duct is a sign of extremely locally advanced gallbladder carcinoma; therefore, prophylactic combined bile duct resection has no survival impact for patients without extrahepatic bile duct invasion.

Entities:  

Mesh:

Year:  2015        PMID: 25663014     DOI: 10.1007/s00268-015-3011-y

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  20 in total

1.  Combined portal vein and liver resection for carcinoma of the biliary tract.

Authors:  Y Nimura; N Hayakawa; J Kamiya; S Maeda; S Kondo; A Yasui; S Shionoya
Journal:  Br J Surg       Date:  1991-06       Impact factor: 6.939

2.  Cancer cells spread through lymph vessels in the submucosal layer of the common bile duct in gallbladder carcinoma.

Authors:  Akira Chikamoto; Tatsuya Tsuji; Osamu Nakahara; Yasuo Sakamoto; Yoshiaki Ikuta; Hiroshi Tanaka; Hiroshi Takamori; Masahiko Hirota; Keiichiro Kanemitsu; Hideo Baba
Journal:  J Hepatobiliary Pancreat Surg       Date:  2009-04-18

3.  Should the extrahepatic bile duct be resected or preserved in R0 radical surgery for advanced gallbladder carcinoma? Results of a Japanese Society of Biliary Surgery Survey: a multicenter study.

Authors:  Tatsuo Araida; Ryouta Higuchi; Mie Hamano; Yoshihito Kodera; Nobuhiro Takeshita; Takehiro Ota; Tatsuya Yoshikawa; Masakazu Yamamoto; Ken Takasaki
Journal:  Surg Today       Date:  2009-09-24       Impact factor: 2.549

4.  Clinical significance of extrahepatic bile duct resection for advanced gallbladder cancer.

Authors:  Yoshihiro Sakamoto; Tomoo Kosuge; Kazuaki Shimada; Tsuyoshi Sano; Taizo Hibi; Junji Yamamoto; Tadatoshi Takayama; Masatoshi Makuuchi
Journal:  J Surg Oncol       Date:  2006-09-15       Impact factor: 3.454

5.  Surgical strategy for T2 and T3 gallbladder cancer: is extrahepatic bile duct resection always necessary?

Authors:  Sae Byeol Choi; Hyung Joon Han; Wan Bae Kim; Tae Jin Song; Sung Ock Suh; Sang Yong Choi
Journal:  Langenbecks Arch Surg       Date:  2013-09-21       Impact factor: 3.445

6.  Gallbladder cancer: Defining the indications for primary radical resection and radical re-resection.

Authors:  Jason M Foster; Hisakazu Hoshi; John F Gibbs; Renuka Iyer; Miland Javle; Quyen Chu; Boris Kuvshinoff
Journal:  Ann Surg Oncol       Date:  2006-11-11       Impact factor: 5.344

7.  Analysis of the extent of resection for adenocarcinoma of the gallbladder.

Authors:  Michael D'Angelica; Kimberly Moore Dalal; Ronald P DeMatteo; Yuman Fong; Leslie H Blumgart; William R Jarnagin
Journal:  Ann Surg Oncol       Date:  2008-11-05       Impact factor: 5.344

8.  Evaluation of venous invasion by Elastica van Gieson stain and tumor budding predicts local and distant metastases in patients with T1 stage colorectal cancer.

Authors:  Akifumi Suzuki; Kazutomo Togashi; Mitsuhiro Nokubi; Koji Koinuma; Yasuyuki Miyakura; Hisanaga Horie; Alan T Lefor; Yoshikazu Yasuda
Journal:  Am J Surg Pathol       Date:  2009-11       Impact factor: 6.394

9.  New classification of cystic duct carcinoma.

Authors:  Y Yokoyama; H Nishio; T Ebata; T Abe; T Igami; K Oda; Y Nimura; M Nagino
Journal:  World J Surg       Date:  2008-04       Impact factor: 3.352

10.  Perineural invasion has a negative impact on survival of patients with gallbladder carcinoma.

Authors:  R Yamaguchi; M Nagino; K Oda; J Kamiya; K Uesaka; Y Nimura
Journal:  Br J Surg       Date:  2002-09       Impact factor: 6.939

View more
  5 in total

1.  MicroRNA-155 expression as a prognostic factor in patients with gallbladder carcinoma after surgical resection.

Authors:  Xue-Lin Zhang; Jun-Hong Chen; Cheng-Kun Qin
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  5-Aminolevulinic-acid-mediated Photodynamic Diagnosis Enhances the Detection of Peritoneal Metastases in Biliary Tract Cancer in Mice.

Authors:  Toshihiro Kushibiki; Takehiro Noji; Yuma Ebihara; Koji Hontani; Masato Ono; Shota Kuwabara; Toru Nakamura; Takahiro Tsuchikawa; Keisuke Okamura; Masahiro Ishizuka; Satoshi Hirano
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

Review 3.  MicroRNA expression and its implications for diagnosis and therapy of gallbladder cancer.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; Priscilla T Y Law; Matthew T V Chan; William K K Wu
Journal:  Oncotarget       Date:  2015-06-10

4.  Surgical treatment of gallbladder cancer: An eight-year experience in a single center.

Authors:  Yasuyuki Kamada; Tomohide Hori; Hidekazu Yamamoto; Hideki Harada; Michihiro Yamamoto; Masahiro Yamada; Takefumi Yazawa; Masaki Tani; Asahi Sato; Ryotaro Tani; Ryuhei Aoyama; Yudai Sasaki; Masazumi Zaima
Journal:  World J Hepatol       Date:  2020-09-27

5.  MRNA Profiling Involved in Triggering of STAT1 with Regulatory Involvement of IRF7, PTPRF, and miR-145p in Patients Suffering from Gall Bladder Carcinoma.

Authors:  Weiwei Zhao; Yanxuan Gong; Yugang Chen
Journal:  J Healthc Eng       Date:  2022-01-07       Impact factor: 3.822

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.